Moreover, esculetin effectively decreased the cell viability and inhibited tumor growth of HCT115, HCT116, and DLD-1 cells, and impaired tumor growth in a colon cancer xenograft mouse model by reducing protein levels of Cyclin D1, c-Myc and Ki-67 [155]. This evidence concerns the gene MYC and colonic neoplasm.